People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vineti, Inc. | — | Biotechnology | Series C | $115.7M | $2.8B | 2020 |
| Propagenix Inc. | — | Biotechnology | Series A | $8.8M | $235.0M | 2016 |
John Kontor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Kontor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nina Kjellson | 1 | 11 |
| Emily Melton | 1 | 10 |
| Risa Stack | 1 | 9 |
| Rowan Chapman | 1 | 7 |
| Eli Casdin | 1 | 6 |
| David Ross | 1 | 5 |
| Michael Pellini | 1 | 4 |
| Chris Krueger | 1 | 3 |
| Joseph DePinto | 1 | 2 |
| Amy DuRoss | 1 | 2 |
| Sharon Challberg | 1 | 1 |
| Brian Pollok | 1 | 1 |
| Neil Kurtz | 1 | 1 |
| Michele Holcomb | 1 | 1 |
| David Mayhew | 1 | 1 |
| Nigel Darby | 1 | 1 |
| Jason Bowman | 1 | 1 |
| Greg Betterton | 1 | 1 |
| Edward Maker | 1 | 1 |
| Wlodek Krawiec | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.